a
HomeCurrent EditionDr. Emmanouela Gbandi appointed Senior Trial Coordinator at CRCTU, University of Birmingham

Dr. Emmanouela Gbandi appointed Senior Trial Coordinator at CRCTU, University of Birmingham

Dr. Emmanouela Gbandi appointed Senior Trial Coordinator at CRCTU, University of Birmingham

Dr. Emmanouela Gbandi appointed Senior Trial Coordinator at CRCTU, University of Birmingham

– BBC NEWS/ NHS Choices

University of Birmingham University hires cancer expert to speed-up trials

It’s hoped more children with a rare form of cancer will be helped after the University of Birmingham appointed the country’s first co-ordinator to support families.

Neuroblastoma affects 100 children a year in the UK. Dr Emmanouela Gbandi who has taken on the role will help children and their families find potentially life saving clinical trials more quickly, says the hospital.

What is neuroblastoma?

• It is a rare type of cancer that mostly affects babies and young children

• It develops from specialised nerve cells (neuroblasts) left behind from a baby’s development in the womb

• It affects about 100 children each year in the UK

• The cause is unknown • In very rare cases children in the same family can be affected, but generally neuroblastoma does not run in families

Source: BBC NEWS/ NHS Choices

Share With:
Rate This Article
Author

info@africanheritagemagazine.de

No Comments

Sorry, the comment form is closed at this time.